Clinical Trials Browser

NIH × Anemia, Aplastic × Classical hematology × Clear all

NCT06303193 2026-03-18

Pacritinib, a Kinase Inhibitor of CSF1R, IRAK1, JAK2, and FLT3, in Adults and Pediatric Participants 12 Years of Age or Older With Myelodysplastic Syndromes or Myelodysplastic/Myeloproliferative Neoplasms

Anemia, Aplastic, Anemia, Refractory, with Excess of Blasts, Bone Marrow Diseases, Myelodysplastic Syndromes, Myeloproliferative Disorders

NCT00027274 2026-03-12

Cancer in Inherited Bone Marrow Failure Syndromes

Recruiting

4,000 enrolled

Classical hematologyDermatologic

Congenital Bone Marrow Failure Syndromes, Shwachman-Diamond Syndrome, Anemia, Aplastic, Fanconi Anemia, Dyskeratosis Congenita, Anemia, Diamond-Blackfan

NCT00895739 2013-08-12

Alemtuzumab and Low-Dose Cyclosporine in Treating Patients With Severe Aplastic Anemia or Acquired Marrow Failure

Phase 2 Unknown

50 enrolled

Classical hematology

Anemia, Aplastic, Neoplasms

NCT00315419 2010-04-21

Identifying Characteristics of Bone Marrow Failure Syndromes

Unknown

450 enrolled

Classical hematologyMyeloidOther hematologic neoplasm

Bone Marrow Failure Disorders, Anemia, Aplastic, Hemoglobinuria, Paroxysmal, Leukemia, Lymphoid, Myelodysplastic Syndromes, Purpura, Thrombocytopenic, Red-Cell Aplasia, Pure, Leukemia, Large Granular Lymphocytic

NCT00011453 2005-06-24

Protection Against Benzene Toxicity

Completed

Classical hematologyOther hematologic neoplasm

Anemia, Aplastic, Leukemia